Natco Pharma Ltd.

Financial

	Natco Pharma	Orchid Pharma	Biocon
Operational Metrics
API Sector
US DMF Filings	55.0 .	n/a	n/a
Pharmaceutical Sector
Number of ANDA's Filed in USA	51.0 .	n/a	n/a
Number of ANDA's Approved By USFDA	41.0 .	n/a	n/a
Domestic Sales Growth - YoY	31.2 %	n/a	7.7 %
R&D as a % of Total Sales	8.0 %	n/a	8.0 %
Financials
5 yr Average ROE	12.01 %	-7.68 %	9.2 %
5yr average Equity Multiplier	1.19	0.59	2.34
5yr Average Asset Turnover Ratio	0.44	0.38	0.39
5yr Avg Net Profit Margin	22.3 %	-6.96 %	10.15 %
Price to Book	3.65	4.93	2.16
P/E	15.39	62.59	41.85
5yr Avg Cash Conversion Cycle	55.67 Days	49.91 Days	-81.57 Days
Inventory Days	103.24 Days	112.74 Days	82.47 Days
Days Receivable	93.53 Days	105.72 Days	91.14 Days
Days Payable	180.2 Days	255.1 Days	232.53 Days
5yr Average Interest Coverage Ratio	37.72	0.47	15.21
5yr Avg ROCE	15.05 %	-4.58 %	9.08 %
5yr Avg Operating Profit Margin	34.37 %	10.74 %	27.02 %
5 yr average Debt to Equity	0.07	-0.45	0.58
5yr CAGR Net Profit	2.11 %	-7.77 %	-12.56 %
5yr Average Return on Assets	10.04 %	-2.51 %	4.23 %
Shareholdings
Promoter Holding	49.71 %	69.84 %	60.64 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.84 %	-28.23 %	-0.03 %
Change in Mutual Fund Holding (3 Yrs)	-5.37 %	15.18 %	6.06 %

Business

	Natco Pharma	Orchid Pharma	Biocon
Product Wise Break-Up	Product Wise Break-Up Formulations 90.72 Active Pharmaceutical Ingredient (API) 4.5 Crop Health 0 Sterile 0 Oral Formulations 0 Generics 0 Novel 0 Biosimilars 0 Syngene (Research Services) 0 Branded Formulations 0 Biologics 0 Others 4.78	Product Wise Break-Up Active Pharmaceutical Ingredient (API) 0 Oral Formulations 68.28 Syngene (Research Services) 0 Generics 0 Sterile 31.72 Crop Health 0 Branded Formulations 0 Formulations 0 Novel 0 Biologics 0 Biosimilars 0	Product Wise Break-Up Active Pharmaceutical Ingredient (API) 0 Oral Formulations 0 Syngene (Research Services) 22.96 Generics 17.99 Sterile 0 Crop Health 0 Branded Formulations 0 Formulations 0 Novel 0 Biologics 0 Biosimilars 59.05
Segment Break-Up	Segment Break-Up Pharmaceuticals 100.0 Agrochemicals 0	-	-
Therapeutic Area Wise Break-Up - Domestic	Therapeutic Area Wise Break-Up - Domestic Oncology 58.79 Others 41.21	-	-
Location Wise Break-Up	Location Wise Break-Up USA 59.55 Rest of the World 22.23 India 18.22 Ireland 0	Location Wise Break-Up Rest of the World 0 Ireland 0 USA 0 India 15.85 Others 84.15	Location Wise Break-Up Rest of the World 37.4 Ireland 10.55 USA 37.08 India 14.98
Operating Profit Break-Up	Operating Profit Break-Up Pharmaceuticals 100.0 Agrochemicals 0	-	Operating Profit Break-Up Pharmaceuticals 0 Agrochemicals 0 Others 100
Asset Break-Up	Asset Break-Up Pharmaceuticals 91.5 Agrochemicals 8.5 Novel Biologics 0 Research 0 Biosimilars 0 Generics 0	-	Asset Break-Up Pharmaceuticals 0 Novel Biologics 0 Generics 12.6 Agrochemicals 0 Research 10.91 Biosimilars 76.49

Natco Pharma Ltd.

SIGN UP FOR FREE